Trial reportScience progress
Preliminary results of one-stage repair of residual aortic dissection using dense mesh stent combined with release and post-processing techniques.
Trial report in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThis study aims to preliminarily evaluate the early safety and efficacy of one-stage repair of residual aortic dissection using dense metal mesh stents combined with improved release and post-processing techniques.MethodsA prospective, single-center, single-arm clinical trial was designed and implemented, enrolling patients with residual aortic dissection to undergo metal mesh stent implantation under guidance of stent release and post-processing techniques. Patients received aortic CTA follow-up at 30 days post-surgery to assess early safety and efficacy.ResultsA total of 25 patients were enrolled, 14 in the (sub)acute phase and 11 in the chronic phase. No postoperative deaths, reinterventions, or aortic-related adverse events like malperfusion or ischemia were reported. The immediate technical success rate was 100%. For (sub)acute cases, the true lumen volume increased by 176.10%, while the false lumen decreased by 83.95%. False lumen thrombosis was grade II in two patients (14.29%), grade III in seven (50.00%), and grade IV in five (35.71%). For chronic cases, the true lumen volume increased by 96.92%, while the false lumen decreased by 73.43%. Thrombosis was grade II in three patients (27.27%), grade III in five (45.45%), and grade IV in three (27.27%). Postoperative aortic CTA showed that all visceral artery branches remained patent, and high-risk ischemic branches were converted to non-high-risk.ConclusionsPreliminary results suggest that dense mesh stents combined with release and post-processing techniques have acceptable early safety and efficacy. For acute and chronic residual aortic dissection patients with visceral artery branch involvement, this method may offer an alternative treatment option. Registration no. ChiCTR2200055277.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.